|
NFS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.047900E-02 |
| Normal-vs-Stage3 |
2.05391259555654E-14 |
| Normal-vs-Stage4 |
1.62525548574877E-12 |
| Stage1-vs-Stage2 |
2.203400E-04 |
| Stage1-vs-Stage3 |
5.557800E-01 |
| Stage1-vs-Stage4 |
8.397900E-02 |
| Stage2-vs-Stage3 |
1.808030E-04 |
| Stage2-vs-Stage4 |
1.67244000000011E-05 |
| Stage3-vs-Stage4 |
2.696800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.57180000126544E-08 |
| Normal-vs-Asian |
1.12099995952519E-10 |
| Caucasian-vs-AfricanAmerican |
7.764800E-01 |
| Caucasian-vs-Asian |
6.081000E-01 |
| AfricanAmerican-vs-Asian |
9.262800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.48543457721007E-13 |
| Normal-vs-Female |
9.99200722162641E-16 |
| Male-vs-Female |
7.690600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
5.32907051820075E-15 |
| Normal-vs-Age(61-80Yrs) |
4.26469999981194E-07 |
| Normal-vs-Age(81-100Yrs) |
4.09730000000552E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.169200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.290350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.180400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.949800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.781200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.270600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.98339999990927E-07 |
| Classical-VS-Follicular |
1.07640000002185E-06 |
| Classical-VS-Other |
9.903200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.17734727417474E-12 |
| Tall-VS-Other |
1.270160E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.252990E-01 |
| Follicular-VS-Normal |
7.357900E-03 |
| Other-VS-Normal |
1.367080E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.96604971086845E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
4.40440000000208E-05 |
|
|
